These results suggest that the effect of AR antagonists in BC cell lines can be AR-independent
These results suggest that the effect of AR antagonists in BC cell lines can be AR-independent. in tumorsphere formation efficiency, high aldehyde dehydrogenase activity, and CSC markers. Surprisingly, we found that AR antagonists inhibited proliferation of most BC cell lines in an AR-independent manner, raising questions regarding their mechanism of action. In summary, AR/VDR-targeted agonist hormone therapy can inhibit HR2-av TNBC through multiple mechanisms in a receptor-dependent manner Flupirtine maleate and can be combined with chemotherapy. Electronic supplementary material The online version of this article (doi:10.1007/s10549-016-3807-y) contains supplementary material, which is available to authorized users. test using a cut-off of (and SUM-1315), (BT-20, MDA-MB-468 and SUM-159PT), and (MFM-223 and CAL-148) cell lines (Fig.?1d). In addition to confirming these phenotypes with western blots, we tested the response of these cell lines…